Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 5,400.00
+515.00 (10.54%)
At close: Oct 28, 2025
Pharos iBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Operating Revenue | - | - | - | 300 | 57 | 187.68 | Upgrade |
Other Revenue | - | - | - | - | -0 | - | Upgrade |
| - | - | - | 300 | 57 | 187.68 | Upgrade | |
Revenue Growth (YoY) | - | - | - | 426.32% | -69.63% | -55.43% | Upgrade |
Cost of Revenue | 15.91 | 25.93 | 11.02 | 192.49 | 52.09 | 213.76 | Upgrade |
Gross Profit | -15.91 | -25.93 | -11.02 | 107.52 | 4.91 | -26.08 | Upgrade |
Selling, General & Admin | 2,932 | 3,276 | 3,226 | 2,988 | 2,459 | 1,481 | Upgrade |
Research & Development | 7,681 | 8,458 | 6,138 | 7,085 | 5,544 | 4,340 | Upgrade |
Amortization of Goodwill & Intangibles | 72.61 | 71.31 | 69.18 | 67.33 | 111.15 | 52.11 | Upgrade |
Other Operating Expenses | 44.72 | 38.31 | 56.29 | 75.93 | 57.34 | 44.09 | Upgrade |
Operating Expenses | 11,482 | 12,575 | 10,106 | 10,727 | 8,411 | 6,021 | Upgrade |
Operating Income | -11,498 | -12,601 | -10,117 | -10,619 | -8,406 | -6,047 | Upgrade |
Interest Expense | -6.16 | -6.01 | -11.24 | -3,222 | -6,513 | -4,278 | Upgrade |
Interest & Investment Income | 571.11 | 809.98 | 690.24 | 320.48 | 116.43 | 105.06 | Upgrade |
Currency Exchange Gain (Loss) | -140.13 | 717.62 | 28.37 | 346.05 | 205.32 | -180.24 | Upgrade |
Other Non Operating Income (Expenses) | 547.9 | 556.6 | 592.65 | -3,911 | -16,877 | -2,971 | Upgrade |
EBT Excluding Unusual Items | -10,525 | -10,523 | -8,817 | -17,086 | -31,474 | -13,371 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -27.15 | Upgrade |
Gain (Loss) on Sale of Assets | - | -37.27 | -41.7 | 24.43 | 3.2 | - | Upgrade |
Pretax Income | -10,525 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade |
Net Income | -10,525 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade |
Net Income to Common | -10,525 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 12 | 9 | 6 | 6 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 12 | 9 | 6 | 6 | Upgrade |
Shares Change (YoY) | 2.28% | 6.79% | 36.26% | 53.03% | 2.65% | 1.86% | Upgrade |
EPS (Basic) | -813.61 | -817.18 | -732.03 | -1921.10 | -5422.59 | -2369.66 | Upgrade |
EPS (Diluted) | -813.61 | -817.18 | -732.03 | -1921.10 | -5422.59 | -2369.66 | Upgrade |
Free Cash Flow | -9,048 | -10,004 | -8,253 | -8,512 | -8,489 | -5,551 | Upgrade |
Free Cash Flow Per Share | -699.46 | -774.15 | -681.98 | -958.46 | -1462.70 | -981.82 | Upgrade |
Gross Margin | - | - | - | 35.84% | 8.61% | -13.90% | Upgrade |
Operating Margin | - | - | - | -3539.83% | -14747.27% | -3221.86% | Upgrade |
Profit Margin | - | - | - | -5687.23% | -55211.96% | -7138.82% | Upgrade |
Free Cash Flow Margin | - | - | - | -2837.42% | -14892.94% | -2957.82% | Upgrade |
EBITDA | -10,673 | -11,798 | -9,432 | -10,041 | -8,056 | -5,891 | Upgrade |
D&A For EBITDA | 824.61 | 802.91 | 684.91 | 578.1 | 350.09 | 155.37 | Upgrade |
EBIT | -11,498 | -12,601 | -10,117 | -10,619 | -8,406 | -6,047 | Upgrade |
Advertising Expenses | - | 47.12 | - | - | 0.2 | 0.08 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.